Blockade of mIL‐6R alleviated lipopolysaccharide‐induced systemic inflammatory response syndrome by suppressing NF‐κB‐mediated Ccl2 expression and inflammasome activation.
- Resource Type
- Article
- Source
- MedComm; Jun2022, Vol. 3 Issue 2, p1-20, 20p
- Subject
SYSTEMIC inflammatory response syndrome CYTOKINES PYROPTOSIS MULTIPLE organ failure INTERLEUKIN-6 - Language
- ISSN
- 26882663